HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Man Xu Selected Research

Uterine Cervical Neoplasms (Cancer of the Cervix)

9/2020Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles.
12/2014B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Man Xu Research Topics

Disease

38Neoplasms (Cancer)
01/2022 - 06/2002
12Cardiomegaly (Heart Hypertrophy)
08/2022 - 05/2015
11Fibrosis (Cirrhosis)
08/2022 - 10/2003
10Inflammation (Inflammations)
01/2020 - 11/2015
10Infections
11/2019 - 01/2014
9Nasopharyngeal Carcinoma
01/2021 - 01/2012
7Hypertrophy
08/2022 - 05/2015
6Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 08/2016
6Syphilis
01/2021 - 02/2016
6Hypoxia (Hypoxemia)
01/2019 - 06/2013
6Lymphatic Metastasis
01/2019 - 01/2013
5Lung Neoplasms (Lung Cancer)
01/2022 - 01/2019
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2012
5Papillary Thyroid Cancer
01/2019 - 01/2014
4Hyperplasia
01/2017 - 01/2013
3Glioma (Gliomas)
01/2021 - 07/2020
3Breast Neoplasms (Breast Cancer)
01/2021 - 04/2010
3Neuroblastoma
01/2021 - 04/2012
3Heart Failure
01/2021 - 01/2019
3Atherosclerosis
01/2021 - 10/2016
3Neoplasm Metastasis (Metastasis)
01/2020 - 05/2016
3Squamous Cell Carcinoma of Head and Neck
01/2020 - 01/2013
3Hypertension (High Blood Pressure)
01/2020 - 08/2016
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 10/2018
3Carcinoma (Carcinomatosis)
01/2018 - 01/2015
3Ischemia
04/2015 - 10/2009
2COVID-19
06/2022 - 10/2020
2Adenoma (Adenomas)
01/2022 - 01/2015
2Chronic Renal Insufficiency
11/2021 - 01/2020
2Ureteral Obstruction
11/2021 - 01/2018
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2021 - 09/2019
2Keratoconus
11/2020 - 06/2019
2Colonic Neoplasms (Colon Cancer)
09/2020 - 05/2020
2Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020 - 12/2014
2Stomach Neoplasms (Stomach Cancer)
01/2020 - 06/2002
2Choroidal Neovascularization
01/2020 - 01/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2019 - 11/2019
2Carcinogenesis
11/2019 - 04/2010
2Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 06/2018
2Burns
01/2019 - 07/2016
2Sepsis (Septicemia)
12/2018 - 01/2018
2Necrosis
02/2018 - 01/2017
2Pathologic Processes
12/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2010
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 04/2012
8Messenger RNA (mRNA)IBA
09/2021 - 04/2010
6CytokinesIBA
05/2022 - 01/2014
6AntigensIBA
01/2021 - 11/2012
6Pharmaceutical PreparationsIBA
12/2020 - 04/2012
5Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2019
5Angiotensin IIIBA
01/2021 - 05/2015
5VaccinesIBA
01/2021 - 10/2010
5Acetylcholine (Acetylcholine Chloride)FDA Link
01/2017 - 04/2015
4Biological ProductsIBA
01/2022 - 07/2015
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 10/2018
4Cisplatin (Platino)FDA LinkGeneric
09/2020 - 09/2012
4Immunoglobulin M (IgM)IBA
09/2019 - 02/2016
3Long Noncoding RNAIBA
06/2022 - 01/2021
3Interleukin-6 (Interleukin 6)IBA
05/2022 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
3LipidsIBA
12/2020 - 04/2019
3EpitopesIBA
01/2019 - 01/2010
3Choline (Choline Chloride)IBA
01/2019 - 12/2015
3AntibodiesIBA
11/2018 - 01/2010
3FlagellinIBA
01/2018 - 02/2016
2TriterpenesIBA
08/2022 - 01/2018
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
08/2022 - 01/2022
2AntioxidantsIBA
01/2022 - 07/2015
2Phosphotransferases (Kinase)IBA
01/2022 - 05/2015
2Aurora Kinase AIBA
11/2021 - 01/2020
2Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2015
2Mechanistic Target of Rapamycin Complex 1IBA
01/2021 - 01/2020
2Small Interfering RNA (siRNA)IBA
01/2021 - 10/2019
2Bevacizumab (Avastin)FDA Link
01/2021 - 07/2020
2AcidsIBA
09/2020 - 08/2019
2Docetaxel (Taxotere)FDA Link
09/2020 - 09/2012
2CilomilastIBA
01/2020 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2020 - 09/2019
2Histone DemethylasesIBA
11/2019 - 12/2018
2salecanIBA
02/2019 - 01/2017
2HydrogelsIBA
02/2019 - 01/2017
2AlkaliesIBA
01/2019 - 07/2016
2Immunoglobulin G (IgG)IBA
11/2018 - 01/2018
2celastrolIBA
10/2018 - 01/2018
2Estrogens (Estrogen)FDA Link
06/2018 - 01/2014
2InterleukinsIBA
02/2018 - 01/2017
2IntegrinsIBA
12/2017 - 10/2014
2sesaminIBA
08/2017 - 01/2017
2Membrane Proteins (Integral Membrane Proteins)IBA
01/2017 - 02/2016
2Toll-Like Receptors (Toll-Like Receptor)IBA
08/2016 - 10/2010
2NeuropeptidesIBA
12/2004 - 12/2003

Therapy/Procedure

19Therapeutics
01/2022 - 08/2007
7Radiotherapy
05/2016 - 08/2011
5Drug Therapy (Chemotherapy)
04/2015 - 08/2011
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 01/2012
4Induction Chemotherapy
09/2020 - 01/2017
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018 - 06/2002
2Corneal Cross-Linking
11/2020 - 06/2019
2Chemoradiotherapy
09/2020 - 01/2018